Benign Ulceration as a Manifestation of Soft Tissue Radiation Necrosis: Imaging Findings

References

1. ↵
   Carvalho AL, Nishimoto IN, Califano JA, et al. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005;114:806–16

   CrossRefPubMedWeb of Science
2. ↵
   Alexander FW. Micropathology of radiation reaction in the larynx. Ann Otol Rhinol Laryngol 1963;72:831–41

   FREE Full Text
3. ↵
   Marx RE. Osteoradionecrosis: a new concept for its pathophysiology. J Oral Maxillofac Surg 1983;41:283–88

   CrossRefPubMedWeb of Science
4. ↵
   Mathes SJ, Alexander J. Radiation injury. Surg Oncol Clin N Am 1996;5:809–24

   PubMed
5. Ben-Yosef R, Kapp DS. Persistent and/or late complications of combined radiation therapy and hyperthermia. Int J Hyperthermia 1992;8:733–45

   CrossRefPubMed
6. ↵
   Gibbs IC, Le QT, Shah RD, et al. Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers. Int J Radiat Oncol Biol Phys 2003;57:489–94

   CrossRefPubMed
7. ↵
   Dorland's Illustrated Medical Dictionary. Philadelphia: W.B. Saunders;1988 .
8. ↵
   Becker M, Schroth G, Zbären P, et al. Long-term changes induced by high-dose irradiation of the head and neck region: imaging findings. Radiographics 1997;17:5–26

   PubMedWeb of Science
9. ↵
   Agrawal A, deSilva BW, Buckley BM, et al. Role of the physician versus the patient in the detection of recurrent disease following treatment for head and neck cancer. Laryngoscope 2004;114:232–35

   CrossRefPubMed
10. Quillin SP, Balfe DM, Glick SN. Pharyngography after head and neck irradiation: differentiation of postirradiation edema from recurrent tumor. AJR Am J Roentgenol 1993;161:1205–08

    PubMed
11. ↵
    Epstein JB, Feldman R, Dolor RJ, et al. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head Neck 2003;25:911–21

    CrossRefPubMedWeb of Science
12. ↵
    Epstein JB, Wong FL, Stevenson-Moore P. Osteoradionecrosis: clinical experience and a proposal for classification. J Oral Maxillofac Surg 1987;45:104–10

    CrossRefPubMedWeb of Science
13. ↵
    Beumer J, Harrison R, Sanders B, et al. Osteoradionecrosis: predisposing factors and outcomes of therapy. Head Neck Surg 1984;6:819–27

    CrossRefPubMed
14. ↵
    Mancuso AA, Hanafee WN. Oral cavity and oropharynx including tongue base, floor of mouth and mandible. In: Mancuso AA, Hanafee WN, eds. Computed Tomography and Magnetic Resonance Imaging of the Head and Neck. 2nd ed. Baltimore: Williams and Wilkins;1985 :371–75
15. ↵
    Hermans R, Pameijer FA, Mancuso AA, et al. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone? Radiology 2000;214:683–87

    PubMedWeb of Science
16. ↵
    Bedwinek JM, Shukovsky LJ, Fletcher GH, et al. Osteonecrosis in patients treated with definitive radiotherapy for squamous cell carcinomas of the oral cavity and naso-and oropharynx. Radiology 1976;119:665–67

    CrossRefPubMedWeb of Science
17. Beumer J 3rd, Curtis T, Harrison RE. Radiation therapy of the oral cavity: sequelae and management, part 2. Head Neck Surg 1979;1:392–408

    CrossRefPubMed
18. ↵
    Morrish RB Jr, Chan E, Silverman S Jr, et al. Osteonecrosis in patients irradiated for head and neck carcinoma. Cancer 1981;47:1980–83

    CrossRefPubMedWeb of Science
19. ↵
    Kunkel M, Förster GJ, Reichert TE, et al. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management. Cancer 2003;98:2257–65

    CrossRefPubMedWeb of Science
20. Fogarty GB, Peters LJ, Stewart J, et al. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck 2003;25:138–45

    CrossRefPubMedWeb of Science
21. ↵
    Quon A, Fischbein NJ, McDougal IR, et al. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med 2007;48:58S–67S

    Abstract/FREE Full Text
22. ↵
    Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2–18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 1999;109:970–75

    CrossRefPubMedWeb of Science
23. ↵
    Kapoor V, Fukui MB, McCook BM. Role of 18FFDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging. AJR Am J Roentgenol 2005;184:579–87

    PubMed
24. ↵
    Sakamato H, Nakai Y, Ohashi Y, et al. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose FDG PET of head and neck squamous cell carcinomas. Acta Otolaryngol 1998;538:254–60
25. ↵
    Kitagawa Y, Sadato N, Azuma H, et al. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms. J Nucl Med 1999;40:1132–37

    Abstract/FREE Full Text
26. ↵
    Goerres GW, von Schulthess GK, Hany TF. Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment. AJR Am J Roentgenol 2002;179:1337–43

    CrossRefPubMedWeb of Science
27. ↵
    Kostakoglu L, Goldsmith SJ. PET in assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 2004;45:56–58

    Abstract/FREE Full Text
28. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972–80

    Abstract/FREE Full Text
29. ↵
    Reinhardt MJ, Kubota K, Yamada S, et al. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. J Nucl Med 1997;38:280–87

    Abstract/FREE Full Text
30. ↵
    Terhaard CH, Bongers V, van Rijk PP, et al. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 2001;23:933–41

    CrossRefPubMedWeb of Science
31. ↵
    Hermans R, Pameijer FA, Mancuso AA, et al. CT findings in chondroradionecrosis of the larynx. AJNR Am J Neuroradiol 1998;19:711–18

    Abstract